TENET HEALTHCARE CORP THC Cash Flow

Tenet healthcare corp (THC)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Net income
241	154	127	344	347	466	265	-89	-165	-320	-198	171	178	176	155	103	36	78	157	147	168	76	-19	-1	-37	-104	-36	-40	-17	133	13	-4	79	94	242	1,167	1,139	1,152	0	0	0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and Amortization
845	850	827	826	806	802	810	825	853	870	880	866	859	850	840	820	802	797	829	851	863	849	800	712	624	545	470	461	444	430	414	404	400	398	385	386	383	380	0	0	0
Provision for doubtful accounts
-	-	-	-	-	-	-	-	-	1,434	1,463	1,475	1,456	1,449	1,486	1,490	1,490	1,477	1,442	1,320	1,288	1,305	1,297	1,258	1,145	972	824	820	803	785	766	749	727	717	714	712	717	727	0	0	0
Deferred income tax (benefit) expense
36	137	97	84	102	150	455	389	270	200	-136	-77	10	41	84	106	61	42	42	10	45	30	-29	2	-15	-67	-26	-21	-1	92	37	27	84	81	134	-873	-922	-952	0	0	0
Stock-based compensation expense
44	42	46	49	48	46	49	50	55	59	61	62	65	68	70	71	70	69	60	58	54	51	51	43	37	36	34	34	35	32	31	29	25	24	21	21	22	22	0	0	0
Restructuring Settlement Impairment Provisions and Acquisition Cost
221	185	187	187	181	209	261	544	555	541	524	226	207	202	133	146	317	318	329	322	161	153	148	131	110	103	52	38	30	19	14	16	15	20	27	22	18	10	0	0	0
Gain (Loss) Related to Litigation Settlement
-130	-141	-125	-50	-45	-38	-39	-36	-24	-23	-14	-12	-125	-293	-515	-561	-461	-291	-73	-27	-25	-25	-47	-44	-34	-31	-5	-4	-3	-5	-34	-39	-46	-55	-30	-27	-21	-12	0	0	0
Net Gain on Sale, Consolidation, And Deconsolidation Of Facilities
-12	-15	13	7	16	127	113	224	239	144	142	41	19	151	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-180	-227	-224	-44	-45	1	-2	-140	-165	-164	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-348	-352	-352	-181	-4	0	0	0	-	-	-	-	-	-	-	-
Equity in earnings of unconsolidated affiliates, net of distributions received
46	32	27	24	18	12	5	12	13	18	19	19	21	13	49	69	83	99	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair market value adjustments related to interest rate swap and LIBOR cap agreements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17	-20	-3	0	0	0
Amortization of debt discount and debt issuance costs
34	35	37	44	45	45	44	44	44	44	41	42	42	41	42	41	44	41	39	35	28	28	28	24	21	19	18	20	22	22	23	26	27	30	31	31	31	31	0	0	0
Pre-tax loss (income) from discontinued operations
4	15	14	13	13	4	4	3	3	0	-2	1	-3	-6	0	0	0	-	-	-	-25	-35	-35	-43	-12	-7	-16	-3	-106	-101	-116	-121	-29	-41	-2	-3	-6	10	0	0	0
Other items, net
6	15	13	30	27	21	21	-6	17	18	17	24	5	1	-34	-62	-65	-59	-8	26	31	30	17	11	13	20	24	26	19	12	10	14	5	13	15	7	18	5	0	0	0
Changes in cash from operating assets and liabilities:
Accounts receivable
75	247	272	259	226	134	438	788	1,068	1,448	1,494	1,552	1,597	1,604	1,664	1,578	1,601	1,632	1,711	1,738	1,823	1,896	1,634	1,479	1,293	987	877	863	795	868	885	832	897	850	812	822	766	731	0	0	0
Inventories and other current assets
-44	94	154	191	57	-17	59	51	208	35	-109	-107	-67	83	163	196	74	130	388	356	328	314	32	-41	219	203	112	109	95	59	109	97	-66	35	49	61	127	15	0	0	0
Income taxes
-1	-8	-7	-13	-6	3	38	49	4	38	21	-2	70	8	-22	8	-38	-18	-5	-29	-13	-3	0	0	0	-	8	4	5	5	21	42	46	63	81	73	28	-3	0	0	0
Accounts payable, accrued expenses and other current liabilities
11	36	5	2	-88	-152	-63	-36	-32	-10	-157	-290	-98	-51	-6	229	154	68	424	270	276	505	202	71	205	38	-12	-79	-20	9	41	108	-99	-32	-37	-40	17	-87	0	0	0
Other long-term liabilities
-85	3	-35	-50	-66	-102	-63	-70	1	26	-1	54	42	40	55	32	34	38	37	37	59	44	56	55	-1	13	-22	-18	14	3	25	13	-1	-5	-45	-32	-19	-58	0	0	0
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements
228	192	186	180	162	163	150	126	134	125	647	654	646	691	175	213	236	200	210	170	171	168	193	179	137	114	43	32	59	63	73	72	48	44	34	54	66	83	0	0	0
Net cash used in operating activities from discontinued operations, excluding income taxes
-3	-5	-5	-7	-6	-5	-6	-6	-8	-5	-10	-8	-1	-6	-2	-13	-20	-21	-25	-19	-13	-23	-26	-20	-24	-15	-21	-20	-24	-35	-23	-49	-43	-38	-16	0	3	16	0	0	0
Net Cash Provided by (Used in) Operating Activities
1,352	1,233	963	882	946	1,049	1,290	1,260	1,127	1,200	416	377	597	558	1,042	1,255	1,230	1,026	1,054	793	649	687	723	708	602	589	590	520	603	593	510	522	457	497	499	479	492	472	0	0	0
Cash flows from investing activities:
Purchases of property and equipment — continuing operations
660	670	705	685	666	617	619	627	652	707	753	810	865	875	890	896	866	842	765	769	836	933	1,027	958	839	691	546	511	503	506	531	521	487	467	473	482	471	433	0	0	0
Construction of new and replacement hospitals
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	0	0	0
Purchases of businesses or joint venture interests, net of cash acquired
78	25	39	37	99	113	106	113	60	50	62	49	94	117	316	398	958	940	963	1,022	430	428	1,558	1,541	1,519	1,515	315	214	213	211	66	55	69	84	77	105	83	65	0	0	0
Proceeds from sales of facilities and other assets — continuing operations
33	63	89	102	159	543	499	1,234	1,232	827	826	74	20	573	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of facilities and other assets — discontinued operations
0	17	17	17	17	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of marketable securities, long-term investments and other assets
88	82	86	65	69	199	181	163	161	36	46	54	59	62	78	73	66	60	62	60	55	52	14	12	12	12	14	15	17	17	37	54	57	59	84	78	77	84	0	0	0
Purchases of marketable securities and equity investments
62	62	119	120	122	148	60	116	110	81	66	6	22	39	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term assets
24	24	-11	-8	-6	-15	-11	-5	-9	10	32	40	33	31	0	0	0	-	-	-	2	8	7	12	25	-8	-7	0	-22	9	0	0	0	-	-	-	-	-	-	-	-
Other items, net
-19	0	1	-7	-9	-6	-8	-8	-3	-6	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-3	-4	-2	-4	-4	0	0	0	-	-	-	-	-3	0	0	0
Net cash used in investing activities
-684	-619	-661	-643	-627	-115	-86	554	583	21	-53	-792	-939	-430	-195	-278	-810	-1,317	-1,680	-1,731	-1,218	-1,322	-2,569	-2,480	-2,351	-2,164	-825	-674	-630	-662	-525	-520	-510	-503	-473	-525	-481	-420	0	0	0
Cash flows from financing activities:
Repayments of borrowings under credit facility
2,385	2,640	2,325	1,685	1,445	950	625	1,230	970	970	1,550	800	900	1,895	2,130	2,695	3,120	2,815	2,345	2,445	2,455	2,430	2,250	1,966	1,751	1,286	1,316	1,420	1,518	1,773	1,823	1,338	820	365	0	0	0	-	-	-	-
Proceeds from borrowings under credit facility
2,695	2,640	2,600	1,875	1,635	950	625	1,230	970	970	1,550	800	900	1,895	2,020	2,595	2,770	2,595	2,455	2,545	2,635	2,245	2,040	1,933	1,901	1,691	1,351	1,253	1,255	1,693	1,998	1,538	1,103	445	0	0	0	-	-	-	-
Repayments of other borrowings
4,559	6,131	6,158	1,819	1,841	312	278	3,271	4,141	4,139	4,141	1,107	205	154	150	133	2,055	2,049	2,039	2,607	691	683	3,801	3,234	4,258	5,133	2,159	2,148	1,143	248	915	908	846	843	4	876	880	886	0	0	0
Proceeds from other borrowings
4,219	5,719	5,726	1,525	1,523	23	22	2,972	3,796	3,795	4,544	1,597	765	760	-46	-29	2,758	3,158	3,208	3,687	1,409	1,608	6,208	5,708	6,257	6,507	2,707	2,707	1,942	1,092	0	0	0	-	-	-	-	601	0	0	0
Repurchases of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	400	400	292	200	126	204	328	400	374	0	0	0	-	-	-	-
Cash dividends on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14	19	24	24	24	24	24	24	24	0	0	0
Debt issuance costs
53	70	63	18	18	0	0	33	60	62	0	0	0	-	-	-	-	80	77	80	20	27	149	143	150	154	45	45	32	17	0	0	0	-	-	-	-	-	-	-	-
Distributions paid to noncontrolling interests
309	307	294	292	298	288	297	275	259	258	245	246	237	218	196	182	143	110	80	48	45	45	39	37	32	27	24	19	18	15	11	12	11	10	10	9	9	8	0	0	0
Proceeds from sale of noncontrolling interests
19	21	21	22	19	20	16	24	26	31	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of noncontrolling interests
8	11	12	11	641	647	650	1,366	738	729	0	0	0	-	-	-	-	268	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options and employee stock purchase plan
13	12	5	5	8	16	17	18	14	7	0	0	0	-	-	-	-	15	18	24	27	26	23	12	13	22	28	28	24	11	0	0	0	-	-	-	-	-	-	-	-
Contributions from noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other items, net
61	4	12	5	17	54	37	45	54	29	23	20	25	16	0	0	0	-	-	-	0	-	-	-	-	5	-5	1	5	6	0	2	4	3	7	7	7	7	0	0	0
Net cash provided by (used in) financing activities
-307	-763	-488	-393	-1,041	-1,134	-1,133	-1,886	-1,308	-1,326	-583	234	186	232	-648	-620	123	454	876	831	613	715	1,964	2,088	1,795	1,324	234	162	18	320	-87	-184	-110	-286	-239	-401	-333	-337	0	0	0
Net increase (decrease) in cash and cash equivalents
361	-149	-186	-154	-722	-200	71	-72	402	-105	-220	-181	-156	360	199	357	543	163	250	-107	44	80	118	316	46	-251	-1	8	-9	251	-102	-182	-163	-292	-213	-447	-322	-285	0	0	0
Supplemental disclosures:
Interest paid, net of capitalized interest
960	946	1,029	959	965	976	974	972	978	939	953	933	930	932	936	941	874	859	758	751	738	726	618	560	406	426	959	783	603	376	-380	-346	-352	-347	-970	-785	-611	-402	0	0	0
Income tax (payments) refunds, net
24	12	19	17	17	25	26	33	54	56	54	48	28	33	34	28	14	7	9	-3	8	8	4	21	-10	-6	-9	-10	-8	-13	-28	-41	12	-10	9	20	-7	34	0	0	0